Location History:
- Wales, GB (2001)
- Wrexham, GB (2002 - 2003)
Company Filing History:
3 out of 105 
3 out of 832,843 Years Active: 2001-2003
Title: Innovations of John Richard Langridge
Introduction
John Richard Langridge is a notable inventor based in Wales, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release formulations. With a total of six patents to his name, Langridge has demonstrated a commitment to advancing medical science and improving patient care.
Latest Patents
Langridge's latest patents focus on sustained release ranolazine formulations. These formulations contain an intimate mixture of ranolazine and a partially neutralized pH-dependent binder. The resulting film is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5. This innovative formulation is suitable for twice daily administration of ranolazine. It is designed to control the rate of dissolution of ranolazine and maintain human plasma ranolazine levels between 550 and 7500 ng base/mL.
Career Highlights
Throughout his career, Langridge has worked with various companies, including Cv Therapeutics, Inc. His work has significantly impacted the pharmaceutical industry, particularly in the area of drug formulation and delivery systems.
Collaborations
Some of Langridge's notable coworkers include Andrew A Wolff and Fiona Baker. Their collaborative efforts have contributed to the success of the projects they have undertaken together.
Conclusion
John Richard Langridge's innovative work in sustained release formulations showcases his dedication to improving healthcare solutions. His contributions continue to influence the pharmaceutical landscape and enhance patient outcomes.